Cancer Treatment Reviews
Volume 29, Issue 3 , Pages 224-225, June 2003

Early androgen suppression may reduce disease progression and improve long term survival compared with deferred androgen suppression in locally advanced prostate cancer:☆☆☆★

Abstracted from: Wilt T, Nair B, MacDonald R, et al. Early versus deferred androgen suppression in the treatment of advanced prostatic cancer (Cochrane Review). The Cochrane Library, Issue 1, 2003. Oxford: Update Software.

Professor and Chairman, Department of Urology, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Sources of funding: Agency for Healthcare Research and Quality, Department of Veterans Affairs Health Services Research and Development Office USA, Minneapolis/VISN-13 Center for Chronic Diseases Outcomes Research.

☆☆ For correspondence: T Wilt, Center for Chronic Disease Outcomes Research, Minneapolis, Minnesota, USA. E-mail: Tim.Wilt@med.va.gov

★ Abstract provided by Bazian Ltd, London.

PII: S0305-7372(03)00119-1

doi:10.1016/S0305-7372(03)00119-1

Cancer Treatment Reviews
Volume 29, Issue 3 , Pages 224-225, June 2003

Article Tools